Utilization and Comparative Effectiveness of Caspofungin and Voriconazole Early after Market Approval in the U.S

OBJECTIVES: Both caspofungin and voriconazole were initially approved by the FDA with very narrow indications. Our aim was to evaluate the utilization patterns and comparative effectiveness of these agents early after marketing before any labeling change occurred. METHODS: This was a retrospective c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ascioglu, Sibel, Chan, K. Arnold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888390/
https://www.ncbi.nlm.nih.gov/pubmed/24427277
http://dx.doi.org/10.1371/journal.pone.0083658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888390/
https://www.ncbi.nlm.nih.gov/pubmed/24427277
http://dx.doi.org/10.1371/journal.pone.0083658

Ejemplares similares